William Bertrand
2020
In 2020, William Bertrand earned a total compensation of $1.6M as Chief Operating Officer at Adaptimmune Therapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,511 |
|---|---|
| Option Awards | $857,661 |
| Salary | $443,456 |
| Other | $30,485 |
| Total | $1,551,113 |
Bertrand received $857.7K in option awards, accounting for 55% of the total pay in 2020.
Bertrand also received $219.5K in non-equity incentive plan, $443.5K in salary and $30.5K in other compensation.
Rankings
In 2020, William Bertrand's compensation ranked 6,694th out of 13,090 executives tracked by ExecPay. In other words, Bertrand earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,694 out of 13,090 | 49th |
Division Manufacturing | 2,785 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,125 out of 2,254 | 50th |
Industry group Drugs | 971 out of 1,954 | 50th |
Industry Biological Products, Except Diagnostic Substances | 231 out of 411 | 44th |
Source: SEC filing on April 21, 2022.
Bertrand's colleagues
We found four more compensation records of executives who worked with William Bertrand at Adaptimmune Therapeutics in 2020.